AstraZeneca plc (AZN) Receives Neutral Rating from BNP Paribas – The Cerbat Gem – BNP Paribas


AstraZeneca plc (AZN) Receives Neutral Rating from BNP Paribas
The Cerbat Gem
AstraZeneca plc logo AstraZeneca plc (LON:AZN)’s stock had its “neutral” rating reissued by equities researchers at BNP Paribas in a report released on Wednesday. They presently have a GBX 5,300 ($66.71) price target on the biopharmaceutical company’s …

and more »



Source link

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

Send this to a friend